ASX - By Stock
|
PER |
Re:
per-chart
|
|
RYNZN
|
828 |
199K |
2 |
21:28 |
21:28 |
ASX - By Stock
|
828
|
199K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
RYNZN
|
828 |
199K |
2 |
20:40 |
20:40 |
ASX - By Stock
|
828
|
199K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
6 |
15:08 |
15:08 |
ASX - By Stock
|
110
|
21K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
12 |
14:54 |
14:54 |
ASX - By Stock
|
110
|
21K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
12 |
14:02 |
14:02 |
ASX - By Stock
|
190
|
76K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
RYNZN
|
34 |
16K |
4 |
10:44 |
10:44 |
ASX - By Stock
|
34
|
16K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
0 |
09:11 |
09:11 |
ASX - By Stock
|
110
|
21K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
6 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
190
|
76K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
190
|
76K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
6 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
190
|
76K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
4 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
190
|
76K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
8 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
110
|
21K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
11 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
110
|
21K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
6 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
110
|
21K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
RYNZN
|
34 |
16K |
1 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
20 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
127
|
30K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
10 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
127
|
30K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
9 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
127
|
30K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
RYNZN
|
34 |
16K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
20 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
190
|
76K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
127
|
30K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
127
|
30K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
RYNZN
|
969 |
350K |
8 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
969
|
350K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
19 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
110
|
21K
|
19
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
RYNZN
|
828 |
199K |
6 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
828
|
199K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
11 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
190
|
76K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
RYNZN
|
969 |
350K |
7 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
969
|
350K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
RYNZN
|
828 |
199K |
4 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
828
|
199K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
12 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
190
|
76K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
11 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
127
|
30K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
7 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
190
|
76K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
20 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
127
|
30K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
13 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
127
|
30K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
17 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
127
|
30K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
28 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
127
|
30K
|
28
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
RYNZN
|
127 |
30K |
9 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
127
|
30K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
7 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
190
|
76K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
5 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
110
|
21K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
14 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
190
|
76K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
12 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
RYNZN
|
190 |
76K |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
190
|
76K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
6 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
4 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
7 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
6 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
5 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
6 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
8 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
8
|
|
ASX - By Stock
|
PER |
Clean insights and information easily found
|
|
RYNZN
|
110 |
21K |
10 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
110
|
21K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
RYNZN
|
102 |
25K |
13 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
25K
|
13
|
|